跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Hansa Biopharma Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
e1ed1f46a7df9d18
Company
Hansa Biopharma Ab
Type
Standard
Approval Details
Approval Id
e1ed1f46a7df9d18
Drug Cima Aemps Name
IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201471001
Holder Company Name
Hansa Biopharma Ab
Marketing Company Name
Hansa Biopharma Ab
Holder Company Detail Path
/organization/hansa-biopharma-ab
Marketing Company Detail Path
/organization/hansa-biopharma-ab
Authorization Date
2021-12-09
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
11 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Hansa Biopharma Ab
Company Detail Path
/organization/hansa-biopharma-ab
Company Information
Pharmaceutical Company Name
Hansa Biopharma AB
Country Name
Norway
City Name
utlandet,country_no
Address
Scheelevägen 22SE-220 07 LUND
Website
http://www.hansabiopharma.com
Active Ingredients
IMLIFIDASA
11 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
e1ed1f46a7df9d18
Type
Standard
Back to CIMA-AEMPS Approvals
IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details